Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study.
about
Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Metformin as an initial adjunc ...... ome: Randomized control study.
@ast
Metformin as an initial adjunc ...... ome: Randomized control study.
@en
type
label
Metformin as an initial adjunc ...... ome: Randomized control study.
@ast
Metformin as an initial adjunc ...... ome: Randomized control study.
@en
prefLabel
Metformin as an initial adjunc ...... ome: Randomized control study.
@ast
Metformin as an initial adjunc ...... ome: Randomized control study.
@en
P2093
P2860
P921
P356
P1476
Metformin as an initial adjunc ...... ome: Randomized control study.
@en
P2093
Andrej Janez
Katja Goricar
Mojca Jensterle
P2860
P304
P356
10.3892/ETM.2016.3081
P577
2016-02-16T00:00:00Z